| 1 |
Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells[J]. Cell Tissue Kinet, 1970, 3(4):393-403.
|
| 2 |
Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease[J]. Nat Rev Immunol, 2008, 8(9):726-736.
|
| 3 |
Shi Y, Su J, Roberts AI, et al. How mesenchymal stem cells interact with tissue immune responses[J]. Trends Immunol, 2012, 33(3):136-143.
|
| 4 |
Zhou BO, Yue R, Murphy MM, et al. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow[J]. Cell Stem Cell, 2014, 15(2):154-168.
|
| 5 |
Sun L, Wang D, Liang J, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus[J]. Arthritis Rheum, 2010, 62(8):2467-2475.
|
| 6 |
Vojtassak J, Danisovic L, Kubes M, et al. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot[J]. Neuro Endocrinol Lett, 2006, 27 Suppl 2:134-137.
|
| 7 |
Caplan AI, Correa D. The MSC: an injury drugstore[J]. Cell stem cell, 2011, 9(1):11-15.
|
| 8 |
Wang Y, Chen XD, Cao W, et al. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications[J]. Nat Immunol, 2014, 15(11):1009-1016.
|
| 9 |
Quante M, Tu SP, Tomita H, et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth[J]. Cancer Cell, 2011, 19(2):257-272.
|
| 10 |
Ren G, Zhao X, Wang Y, et al. CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα[J]. Cell Stem Cell, 2012, 11(6):812-824.
|
| 11 |
Roodhart JM, Daenen LG, Stigter EC, et al. Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids[J]. Cancer Cell, 2011, 20(3):370-383.
|
| 12 |
Kidd S, Spaeth E, Dembinski JL, et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging[J]. Stem Cells, 2009, 27(10):2614-2623.
|
| 13 |
Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas[J]. Cancer Res, 2005, 65(8):3307-3318.
|
| 14 |
Hoogduijn MJ, Verstegen MM, Engela AU, et al. Evidence for circulating mesenchymal stem cells in patients with organ injury[J]. Stem Cells Dev, 2014, 23(19):2328-2335.
|
| 15 |
Stagg J. Mesenchymal stem cells in cancer[J]. Stem Cell Rev, 2008, 4(2):119-124.
|
| 16 |
Jung Y, Kim JK, Shiozawa Y, et al. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis[J]. Nat Commun, 2013, 4:1795.
|
| 17 |
Dwyer RM, Potter-Beirne SM, Harrington KA, et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells[J]. Clin Cancer Res, 2007, 13(17):5020-5027.
|
| 18 |
Wagner W, Wein F, Seckinger A, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood[J]. Exp Hematol, 2005, 33(11):1402-1416.
|
| 19 |
Waite KA, Eng C. From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family[J]. Nat Rev Genet, 2003, 4(10):763-773.
|
| 20 |
Mclean K, Gong Y, Choi Y, et al. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production[J]. J Clin Invest, 2011, 121(8):3206-3219.
|
| 21 |
Ren G, Liu Y, Zhao X, et al. Tumor resident mesenchymal stromal cells endow naïve stromal cells with tumor-promoting properties[J]. Oncogene, 2014, 33(30):4016-4020.
|
| 22 |
Lin LY, Du LM, Cao K, et al. Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities[J]. Oncogene, 2016, 35(46):6038-6042.
|
| 23 |
Beckermann BM, Kallifatidis G, Groth A, et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma[J]. Br J Cancer, 2008, 99(4):622-631.
|
| 24 |
De Boeck A, Pauwels P, Hensen K, et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling[J]. Gut, 2013, 62(4):550-560.
|
| 25 |
Crovello CS, Lai C, Cantley LC, et al. Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2[J]. J Biol Chem, 1998, 273(41):26954-26961.
|
| 26 |
Mandel K, Yang Y, Schambach A, et al. Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo[J]. Stem Cells Dev, 2013, 22(23):3114-3127.
|
| 27 |
Hanahan D, Weinberg RA. Hallmarks of cancer: the next Generation[J]. Cell, 2011, 144(5):646-674.
|
| 28 |
Rosová I, Dao M, Capoccia B, et al. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells[J]. Stem Cells, 2008, 26(8):2173-2182.
|
| 29 |
Wei L, Fraser JL, Lu ZY, et al. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats[J]. Neurobiol Dis, 2012, 46(3):635-645.
|
| 30 |
Chen J, Park HC, Addabbo F, et al. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair[J]. Kidney Int, 2008, 74(7):879-889.
|
| 31 |
Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs[J]. Cell Stem Cell, 2008, 3(3):301-313.
|
| 32 |
Bexell D, Gunnarsson S, Tormin A, et al. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas[J]. Mol Ther, 2009, 17(1):183-190.
|
| 33 |
Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms[J]. Cell, 2011, 147(2):275-292.
|
| 34 |
Gupta GP, Massagué J. Cancer metastasis: building a framework[J]. Cell, 2006, 127(4):679-695.
|
| 35 |
Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis[J]. Nature, 2001, 410(6824):50-56.
|
| 36 |
Zhang Y, Yang P, Sun T, et al. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis[J]. Nat Cell Biol, 2013, 15(3):284-294.
|
| 37 |
Ho IA, Yulyana Y, Sia KC, et al. Matrix metalloproteinase-1-mediated mesenchymal stem cell tumor tropism is dependent on crosstalk with stromal derived growth factor 1/C-X-C chemokine receptor 4 axis[J]. FASEB J, 2014, 28(10):4359-4368.
|